655 related articles for article (PubMed ID: 19758107)
1. Histamine H3 and H4 receptors as novel drug targets.
Tiligada E; Zampeli E; Sander K; Stark H
Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107
[TBL] [Abstract][Full Text] [Related]
2. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
[TBL] [Abstract][Full Text] [Related]
3. Histamine H4 receptor ligands and their potential therapeutic applications.
Kiss R; Keseru GM
Expert Opin Ther Pat; 2009 Feb; 19(2):119-35. PubMed ID: 19441913
[TBL] [Abstract][Full Text] [Related]
4. Histamine receptors in the CNS as targets for therapeutic intervention.
Passani MB; Blandina P
Trends Pharmacol Sci; 2011 Apr; 32(4):242-9. PubMed ID: 21324537
[TBL] [Abstract][Full Text] [Related]
5. The histamine H3 receptor as a therapeutic drug target for CNS disorders.
Gemkow MJ; Davenport AJ; Harich S; Ellenbroek BA; Cesura A; Hallett D
Drug Discov Today; 2009 May; 14(9-10):509-15. PubMed ID: 19429511
[TBL] [Abstract][Full Text] [Related]
6. Major advances in the development of histamine H4 receptor ligands.
Smits RA; Leurs R; de Esch IJ
Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
[TBL] [Abstract][Full Text] [Related]
7. Histamine H4 receptor ligands and their potential therapeutic applications: an update.
Kiss R; Keserű GM
Expert Opin Ther Pat; 2012 Mar; 22(3):205-21. PubMed ID: 22385042
[TBL] [Abstract][Full Text] [Related]
8. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.
Esbenshade TA; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Fox GB; Faghih R; Bennani YL; Williams M; Hancock AA
J Pharmacol Exp Ther; 2003 Jun; 305(3):887-96. PubMed ID: 12606603
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
Geyer R; Kaske M; Baumeister P; Buschauer A
Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
[TBL] [Abstract][Full Text] [Related]
10. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
[TBL] [Abstract][Full Text] [Related]
11. Histamine H4 receptors modulate dendritic cell migration through skin--immunomodulatory role of histamine.
Bäumer W; Wendorff S; Gutzmer R; Werfel T; Dijkstra D; Chazot P; Stark H; Kietzmann M
Allergy; 2008 Oct; 63(10):1387-94. PubMed ID: 18782117
[TBL] [Abstract][Full Text] [Related]
12. The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment.
Medina V; Croci M; Crescenti E; Mohamad N; Sanchez-Jiménez F; Massari N; Nuñez M; Cricco G; Martin G; Bergoc R; Rivera E
Cancer Biol Ther; 2008 Jan; 7(1):28-35. PubMed ID: 17932461
[TBL] [Abstract][Full Text] [Related]
13. Novel histamine H4 receptor ligands and their potential therapeutic applications: an update.
Kiss R; Keseru GM
Expert Opin Ther Pat; 2014 Nov; 24(11):1185-97. PubMed ID: 25219452
[TBL] [Abstract][Full Text] [Related]
14. En route to new blockbuster anti-histamines: surveying the offspring of the expanding histamine receptor family.
Leurs R; Vischer HF; Wijtmans M; de Esch IJ
Trends Pharmacol Sci; 2011 Apr; 32(4):250-7. PubMed ID: 21414671
[TBL] [Abstract][Full Text] [Related]
15. Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders.
Esbenshade TA; Fox GB; Cowart MD
Mol Interv; 2006 Apr; 6(2):77-88, 59. PubMed ID: 16565470
[TBL] [Abstract][Full Text] [Related]
16. Histamine pharmacology and new CNS drug targets.
Tiligada E; Kyriakidis K; Chazot PL; Passani MB
CNS Neurosci Ther; 2011 Dec; 17(6):620-8. PubMed ID: 22070192
[TBL] [Abstract][Full Text] [Related]
17. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
Kottke T; Sander K; Weizel L; Schneider EH; Seifert R; Stark H
Eur J Pharmacol; 2011 Mar; 654(3):200-8. PubMed ID: 21237145
[TBL] [Abstract][Full Text] [Related]
18. The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists.
Hancock AA
Biochem Pharmacol; 2006 Apr; 71(8):1103-13. PubMed ID: 16513092
[TBL] [Abstract][Full Text] [Related]
19. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
Passani MB; Lin JS; Hancock A; Crochet S; Blandina P
Trends Pharmacol Sci; 2004 Dec; 25(12):618-25. PubMed ID: 15530639
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in histamine H3 receptor antagonists/inverse agonists.
Łazewska D; Kieć-Kononowicz K
Expert Opin Ther Pat; 2010 Sep; 20(9):1147-69. PubMed ID: 20716022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
